PlainRecalls
FDA Devices Moderate Class II Ongoing

AMO ADMINISTRATION SET, Article No. 7A3817, REF OM2505191, for ophthalmologic use.

Reported: November 15, 2023 Initiated: September 26, 2023 #Z-0130-2024

Product Description

AMO ADMINISTRATION SET, Article No. 7A3817, REF OM2505191, for ophthalmologic use.

Reason for Recall

Devices may leak as a result of a manufacturing issue. Leakage may result in a delay of therapy, increase risk of bloodstream infection (BSI), and may expose both patients and healthcare workers to hazardous medication. There is also the potential for life-threatening situations to occur requiring additional medical intervention.

Details

Recalling Firm
B. Braun Medical, Inc.
Units Affected
32,000
Distribution
Worldwide distribution - US Nationwide and the countries of Canada and Singapore.
Location
Allentown, PA

Frequently Asked Questions

What product was recalled?
AMO ADMINISTRATION SET, Article No. 7A3817, REF OM2505191, for ophthalmologic use.. Recalled by B. Braun Medical, Inc.. Units affected: 32,000.
Why was this product recalled?
Devices may leak as a result of a manufacturing issue. Leakage may result in a delay of therapy, increase risk of bloodstream infection (BSI), and may expose both patients and healthcare workers to hazardous medication. There is also the potential for life-threatening situations to occur requiring additional medical intervention.
Which agency issued this recall?
This recall was issued by the FDA Devices on November 15, 2023. Severity: Moderate. Recall number: Z-0130-2024.